SciClone Pharmaceuticals, Inc. (SCLN) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
AndrewBaker AndrewBaker 03/14/2012 3 months $6.51 $6.81 +4.61% 4 Ended
Comments: Upcoming product launch will be successful
GeorgeB_1 GeorgeB_1 06/01/2010 3 months N/A Ended
Comments: Bull because of great future potential.
Gregory Bene Gregory Bene 05/17/2010 3 months N/A Ended
Comments: Great potential for the company with its new products.
THEBISTROCFO THEBISTROCFO 02/25/2010 3 months N/A Ended
Comments:
ClownCircus ClownCircus 12/09/2009 3 months N/A Ended
Comments: Growing top and bottom line numbers. China revenues are driving this issue (H1N1). Recommend you take a look at this company - close to Book Value and low PE. Ask your investment advisor and JMHO.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.